JLB & Associates Inc. reduced its position in shares of Genpact Limited (NYSE:G – Free Report) by 4.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 53,480 shares of the business services provider’s stock after selling 2,333 shares during the period. JLB & Associates Inc.’s holdings in Genpact were worth $2,297,000 at the end of the most recent quarter.
Several other large investors have also recently added to or reduced their stakes in the company. Franklin Resources Inc. raised its holdings in shares of Genpact by 6.5% in the third quarter. Franklin Resources Inc. now owns 4,148,185 shares of the business services provider’s stock valued at $162,318,000 after buying an additional 252,674 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Genpact by 12.6% in the third quarter. Geode Capital Management LLC now owns 3,691,406 shares of the business services provider’s stock worth $148,142,000 after acquiring an additional 413,646 shares during the last quarter. JPMorgan Chase & Co. lifted its position in shares of Genpact by 192.8% during the third quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider’s stock worth $122,701,000 after purchasing an additional 2,060,595 shares in the last quarter. Tandem Investment Advisors Inc. grew its stake in shares of Genpact by 390.5% during the fourth quarter. Tandem Investment Advisors Inc. now owns 2,129,915 shares of the business services provider’s stock valued at $91,480,000 after purchasing an additional 1,695,706 shares during the last quarter. Finally, ARGA Investment Management LP increased its holdings in shares of Genpact by 14.1% in the fourth quarter. ARGA Investment Management LP now owns 772,917 shares of the business services provider’s stock valued at $33,197,000 after purchasing an additional 95,413 shares in the last quarter. 96.03% of the stock is owned by institutional investors.
Genpact Trading Down 1.0 %
Shares of NYSE G opened at $54.44 on Friday. Genpact Limited has a twelve month low of $30.23 and a twelve month high of $56.76. The stock has a market cap of $9.60 billion, a price-to-earnings ratio of 19.17, a P/E/G ratio of 1.85 and a beta of 1.20. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50. The company’s fifty day moving average is $46.83 and its 200-day moving average is $42.59.
Genpact Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th will be issued a dividend of $0.17 per share. This is an increase from Genpact’s previous quarterly dividend of $0.15. This represents a $0.68 annualized dividend and a yield of 1.25%. The ex-dividend date of this dividend is Tuesday, March 11th. Genpact’s dividend payout ratio (DPR) is 21.48%.
Analyst Upgrades and Downgrades
Several equities research analysts have recently commented on G shares. Jefferies Financial Group raised Genpact from a “hold” rating to a “buy” rating and lifted their target price for the company from $44.00 to $55.00 in a research note on Tuesday, January 21st. Robert W. Baird boosted their price objective on Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a report on Friday, November 8th. TD Cowen raised shares of Genpact from a “hold” rating to a “buy” rating and raised their target price for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Mizuho lifted their target price on shares of Genpact from $45.00 to $55.00 and gave the stock a “neutral” rating in a report on Monday, February 10th. Finally, Needham & Company LLC increased their price target on Genpact from $55.00 to $65.00 and gave the company a “buy” rating in a research note on Friday, February 7th. Six equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, Genpact has a consensus rating of “Hold” and a consensus price target of $48.44.
View Our Latest Stock Analysis on Genpact
Insider Activity
In related news, CEO Balkrishan Kalra sold 9,000 shares of Genpact stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $46.40, for a total value of $417,600.00. Following the sale, the chief executive officer now owns 267,404 shares of the company’s stock, valued at approximately $12,407,545.60. The trade was a 3.26 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Piyush Mehta sold 12,000 shares of the firm’s stock in a transaction on Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the completion of the transaction, the senior vice president now directly owns 151,182 shares of the company’s stock, valued at $6,475,125.06. This represents a 7.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 34,600 shares of company stock worth $1,538,120 over the last quarter. 2.80% of the stock is currently owned by company insiders.
Genpact Company Profile
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading
- Five stocks we like better than Genpact
- How to Most Effectively Use the MarketBeat Earnings Screener
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- What is the Nasdaq? Complete Overview with History
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Ride Out The Recession With These Dividend KingsĀ
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.